Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma

Abstract

Titers and immunodominant domains recognized by both primary and secondary anti-topo I antibodies are highly variable over time. This suggests continual antigen presentation and regulation of the anti-topo I antibody response in scleroderma, even late in the disease course.